Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Future Growth Projections For The Drug Repurposing Market Size?

The market size for drug repurposing has been witnessing significant growth in recent years. The market is projected to surge from $34.12 billion in 2024 to $37.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.5%. The expansion during the historical period is due to factors like escalated costs associated with pioneering drug development, increase in unsuccessful drug trials, a burgeoning demand for accelerated drug endorsement, greater accessibility of off-patent drugs, and an increase in government and academic research funds.

In the upcoming years, the drug repurposing market is anticipated to witness significant expansion, reaching a valuation of $53.42 billion in 2029 with a compound annual growth rate (CAGR) of 9.3%. The forecasted growth can be credited to the rising demand for affordable treatment options, increased funding from pharmaceutical rivals, intensified partnerships among biotech companies, and broader applications in the fields of oncology and neurology. The forecast period is likely to see trends such as advancements in tools for computational drug discovery, utilization of AI and ML in drug repurposing, innovative predictive modeling for evaluating drug effectiveness, incorporation of large-scale data analytics in drug screening, and progress in the identification of biomarkers.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25758&type=smp

Which Factors Are Steering Growth In The Drug Repurposing Market?

The rising incidence of neurodegenerative conditions is predicted to boost the growth of the drug repurposing market. Neurodegenerative diseases represent a class of illnesses marked by the sustained loss of neuron structure or functionality, even leading to their demise. An increase in such diseases as Alzheimer’s dementia is attributable to heightened life spans since aging stands as the primary risk element fostering the slow loss of neuronal activity over time. Drug repurposing assists neurodegenerative diseases by pinpointing existing drugs with established safety records that can be utilized to focus on disease pathways, hence hastening the formulation of effectual treatments. For example, the Alzheimer’s Association, a US-based not-for-profit health organization, reported in March 2023 that nearly 6.7 million Americans aged 65 or older were living with Alzheimer’s dementia in 2023. The projection indicates a rise to 13.8 million by 2060. Therefore, the increasing occurrence of neurodegenerative diseases is fueling the drug repurposing market’s expansion.

How Is The Drug Repurposing Market Organized By Different Segments?

The drug repurposing market covered in this report is segmented –

1) By Type: Disease-Centric, Target-Centric, Drug-Centric

2) By Drug Molecules: Biologics, Small Molecule

3) By Therapeutic Area: Oncology, Neurology, Infectious Diseases, Cardiovascular Diseases, Autoimmune Disorders

4) By Route Of Administration: Oral, Intravenous, Topical, Inhalation, Intramuscular

5) By End-User: Pharmaceutical Companies, Research And Academic Institutes, Contract Research Organizations

Subsegments:

1) By Disease-Centric: Phenotypic Screening, Epidemiological Analysis, Clinical Observation-Based Repurposing

2) By Target-Centric: Protein Target Modulation, Pathway Modulation, Biomarker-Based Targeting

3) By Drug-Centric: Off-Target Activity Identification, Structure-Based Drug Repositioning, Adverse Effect-Based Repurposing

What Current And Upcoming Trends Are Shaping The Drug Repurposing Market?

Leading corporations in the drug repurposing market are directing their efforts towards the creation of advanced technologies such as drug-protein interaction modelling powered by artificial intelligence (AI) to expedite the discovery of newer therapeutic applications for existing drugs. AI-enabled drug-protein interaction modeling uses artificial intelligence and machine learning to anticipate how drugs will interact with proteins throughout the human proteome, utilizing expansive datasets to improve accuracy and confidence. For example, Cosmos Health Inc., a US healthcare firm, introduced Cloudscreen 2.0, an advanced AI platform for drug repurposing in July 2025. This next-generation system is capable of handling datasets more than 100 times bigger than its predecessor, allowing for a thorough analysis of drug-protein interactions. It includes mutagenesis data and tools for analyzing disordered proteins, targeting diseases like cancer, obesity, and diabetes. The platform’s ability to process on a large scale thanks to graphics processing unit (GPU)-based cloud computing, positions it as a key innovation in speeding up research and development for drug repurposing in numerous therapeutic fields.

Who Are The Most Influential Companies In The Drug Repurposing Market?

Major companies operating in the drug repurposing market are F. Hoffmann-La Roche Ltd , International Business Machines Corporation (IBM), Bayer AG, Takeda Pharmaceutical Company Limited, Amgen Inc., Teva Pharmaceutical Industries Limited, Astellas Pharma Inc., UCB S.A., Eisai Co Ltd., Celltrion Inc., Alnylam Pharmaceuticals Inc., Evotec SE, BenevolentAI Limited, Insilico Medicine Inc., Cosmos Health Inc., Recursion Pharmaceuticals Inc., Pharnext S.A., Healx Ltd., Algernon Pharmaceuticals Inc., BioXcel Therapeutics Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/drug-repurposing-global-market-report

Which Region Dominates The Drug Repurposing Market Today?

North America was the largest region in the drug repurposing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug repurposing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=25758&type=smp

Browse Through More Reports Similar to the Global Drug Repurposing Market 2025, By The Business Research Company

Nicotine Addiction Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nicotine-addiction-treatment-global-market-report

Drug Device Combination Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-device-combination-global-market-report

Drug Discovery Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

About The Business Research Company:

With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model